Post-Market Study MOSKINTO for the treatment of mosquito bites

Post-Market Study MOSKINTO for the treatment of mosquito bites - 2025-Moskinto

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00040318

Enrollment

Registered

2026-05-12

Start date

2026-05-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Itching and swelling after mosquiot bites

Interventions

Group 1: Treatment of mosquito bites in the forearm area with a mosquito patch (Moskinto) Group 2: Non-treatment of mosquito bites in the forearm area as a control Allocation of treatment by randomiza

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 2. Written consent for the study 3. Voluntary mosquito bites on the right and left forearm (4-6 bites per subject and per forearm) 4. Consent to randomization (determining which forearm will be treated with MOSKINTO) 5. Consent to non-treatment of the non-MOSKINTO forearm while participating in the study

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant, trying to become pregnant or breastfeeding. 2. Wounds in the arm area 3. Amputations in the area of both arms 4. Known allergies to patches 5. Known allergies to mosquito bites

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the change in itching after mosquito bites from baseline (15 minutes after mosquito bites before administration of the mosquito patches) to 1 hour. Survey of the subjects	—

Secondary

Measure	Time frame
• Change in itching after mosquito bites from baseline (15 minutes after mosquito bites) to 30 minutes, 3 hours, 6 hours and 24 hours • Change in swelling after mosquito bites from baseline (15 minutes after mosquito bites) to 30 minutes, 1 hour, 3 hours, 6 hours and 24 hours • Assessment of wearing comfort after 24 hours (school grades from 1=very good to 6=unsatisfactory) • Assessment of satisfaction with the MOSKINTO therapy (school grades from 1=very good to 6=unsatisfactory) • Proportion of patients with adverse events, serious adverse events, incident events, serious incidents, and device deficencies	—

Measure

Time frame

• Change in itching after mosquito bites from baseline (15 minutes after mosquito bites) to 30 minutes, 3 hours, 6 hours and 24 hours • Change in swelling after mosquito bites from baseline (15 minutes after mosquito bites) to 30 minutes, 1 hour, 3 hours, 6 hours and 24 hours • Assessment of wearing comfort after 24 hours (school grades from 1=very good to 6=unsatisfactory) • Assessment of satisfaction with the MOSKINTO therapy (school grades from 1=very good to 6=unsatisfactory) • Proportion of patients with adverse events, serious adverse events, incident events, serious incidents, and device deficencies

—

Countries

Germany

Contacts

Public ContactMichael Ramharter

Bernhard Nocht Institute for Tropical Medicine & I Dept. of Medicine University Medical Center Hamburg-Eppendorf

michael.ramharter@ctm.bnitm.de+49-40-285380-511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026